SCHEMBL22128403

SCHEMBL22128403

CCOC(=O)C(C)=Cc1cn(C(=O)OC(C)(C)C)c2ccc(Br)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
HTR6 P50406 1/20 0.40
LMNA P02545 3/20 0.40
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
S1PR4 O95977 1/20 0.38
S1PR1 P21453 1/20 0.38
MAPK1 P28482 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ACHE P22303 1/20 0.36
ELANE P08246 1/20 0.36
KRAS P01116 2/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
GSK3B P49841 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22128401 1.00 L3MBTL1 (0.46) L3MBTL1HTR6LMNAALDH1A1MEN1
SCHEMBL22128307 1.00 L3MBTL1 (0.46) L3MBTL1HTR6LMNAALDH1A1MEN1
SCHEMBL22122297 0.86 LMNA (0.43) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL22122394 0.86 LMNA (0.43) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL2011042 0.82 L3MBTL1 (0.48) L3MBTL1HTR6LMNAALDH1A1MEN1
SCHEMBL7715925 0.81 HTR6 (0.44) L3MBTL1HTR6ALDH1A1MEN1KMT2A
SCHEMBL22128296 0.80 LMNA (0.58) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL22122393 0.80 LMNA (0.58) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL4259833 0.78 LMNA (0.48) LMNAALDH1A1MAPTSMN1; SMN2ELANE
SCHEMBL6638305 0.78 L3MBTL1 (0.72) L3MBTL1HTR6LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240139185-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2024-05-02 US disclosed
CN-113498342-A Compounds involved in synergistic binding and uses thereof 锐新医药公司 2021-10-12 CN disclosed
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240139185-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF KRAS, NRAS, HRAS L3MBTL1 2901/4885HTR6 4101/4885LMNA 4074/4885
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF KRAS, NRAS, HRAS L3MBTL1 2901/4885HTR6 4101/4885LMNA 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.